Use

Monitoring both total and free valproic acid levels in therapy supports accurate therapeutic drug management, especially when protein binding is altered (e.g., by hypoalbuminemia, concomitant medications, pregnancy, or organ dysfunction)—only the free fraction is pharmacologically active and may better reflect efficacy or toxicity, compliance, or risk of toxicity.